MAXCYTE INC. - COMMON
3.3800
26-11月-24 16:45:00
15 分の遅延
株式
-0.2300
-6.37%
本日の幅
3.3300 - 3.6100
ISIN
N/A
ソース
NASDAQ
-
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results
15 3 2023 16:05:23 提供 Nasdaq GlobeNewswire
-
08 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
06 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
01 2 2023 16:05:53 提供 Nasdaq GlobeNewswire
-
03 1 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
05 12 2022 02:00:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter 2022 Financial Results
09 11 2022 16:05:03 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
02 11 2022 08:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2022 Financial Results on November 9, 2022
12 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
28 9 2022 08:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor
21 9 2022 08:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 9 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results
10 8 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022
15 7 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs
12 7 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 5 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter Financial Results
09 5 2022 16:05:03 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
03 5 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022
20 4 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 4 2022 09:00:00 提供 Nasdaq GlobeNewswire